Diadexus, Inc. and OriGene Technologies Sign Exclusive License Agreement for the Development and Commercialization of PLAC(R) ELISA in Asia

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/08/15 -- Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced that it has entered into an exclusive, license and supply agreement granting OriGen ...